Christina R. Lee Biological Sciences Platform Sunnybrook Research Institute Biography Publications Institution JoVE Articles Christina R. Lee has not added a biography. If you are Christina R. Lee and would like to personalize this page please email our Author Liaison for assistance. Publications Preclinical Recapitulation of Antiangiogenic Drug Clinical Efficacies Using Models of Early or Late Stage Breast Cancer Metastatis Breast (Edinburgh, Scotland). Aug, 2013 | Pubmed ID: 24074794 Differential Post-surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis PloS One. 2013 | Pubmed ID: 23967178 Impact of Metronomic UFT/cyclophosphamide Chemotherapy and Antiangiogenic Drug Assessed in a New Preclinical Model of Locally Advanced Orthotopic Hepatocellular Carcinoma Neoplasia (New York, N.Y.). Mar, 2010 | Pubmed ID: 20234820 Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2-positive Human Breast Cancer Xenografts Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2009 | Pubmed ID: 19825954 Glioma Tumor Stem-like Cells Promote Tumor Angiogenesis and Vasculogenesis Via Vascular Endothelial Growth Factor and Stromal-derived Factor 1 Cancer Research. Sep, 2009 | Pubmed ID: 19738068 Tumor and Host-mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Aug, 2009 | Pubmed ID: 19671869 Dose-dependent Increases in Circulating TGF-alpha and Other EGFR Ligands Act As Pharmacodynamic Markers for Optimal Biological Dosing of Cetuximab and Are Tumor Independent Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Apr, 2009 | Pubmed ID: 19276250 Accelerated Metastasis After Short-term Treatment with a Potent Inhibitor of Tumor Angiogenesis Cancer Cell. Mar, 2009 | Pubmed ID: 19249681 Long-term Progression and Therapeutic Response of Visceral Metastatic Disease Non-invasively Monitored in Mouse Urine Using Beta-human Choriogonadotropin Secreting Tumor Cell Lines Molecular Cancer Therapeutics. Oct, 2008 | Pubmed ID: 18852148 Vascular Endothelial Growth Factor-mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels As a Surrogate Biomarker for Tumor Growth Cancer Research. Jan, 2008 | Pubmed ID: 18199548 Multiple Circulating Proangiogenic Factors Induced by Sunitinib Malate Are Tumor-independent and Correlate with Antitumor Efficacy Proceedings of the National Academy of Sciences of the United States of America. Oct, 2007 | Pubmed ID: 17942672 Enhanced Natural-killer Cell and Erythropoietic Activities in VEGF-A-overexpressing Mice Delay F-MuLV-induced Erythroleukemia Blood. Mar, 2007 | Pubmed ID: 17053052 Therapy-induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors Science (New York, N.Y.). Sep, 2006 | Pubmed ID: 16990548 On the Origin and Nature of Elevated Levels of Circulating Endothelial Cells After Treatment with a Vascular Disrupting Agent Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Aug, 2006 | Pubmed ID: 16921064 Highly Efficacious Nontoxic Preclinical Treatment for Advanced Metastatic Breast Cancer Using Combination Oral UFT-cyclophosphamide Metronomic Chemotherapy Cancer Research. Apr, 2006 | Pubmed ID: 16585158 Low-dose Metronomic Combined with Intermittent Bolus-dose Cyclophosphamide is an Effective Long-term Chemotherapy Treatment Strategy Cancer Research. Aug, 2005 | Pubmed ID: 16103050 Friend Virus-induced Erythroleukemias: a Unique and Well-defined Mouse Model for the Development of Leukemia Anticancer Research. May-Jun, 2003 | Pubmed ID: 12894591 Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy Amanda Tracz1, Michalis Mastri1, Christina R. Lee2, Roberto Pili1, John M. L. Ebos1 1Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute, 2Biological Sciences Platform, Sunnybrook Research Institute JoVE 51485 Médecine
Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy Amanda Tracz1, Michalis Mastri1, Christina R. Lee2, Roberto Pili1, John M. L. Ebos1 1Genitourinary Section, Department of Medicine, Roswell Park Cancer Institute, 2Biological Sciences Platform, Sunnybrook Research Institute JoVE 51485 Médecine